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Abstract
Complex microbial ecosystems are increasingly studied through the use of metagenomics approaches. Overwhelming
amounts of DNA sequence data are generated to describe the ecosystems, and allow to search for correlations between
gene occurrence and clinical (e.g. in studies of the gut microbiota), physico-chemical (e.g. in studies of soil or water
environments), or other parameters. Observed correlations can then be used to formulate hypotheses concerning microbial
gene functions in relation to the ecosystem studied. In this context, functional metagenomics studies aim to validate these
hypotheses and to explore the mechanisms involved. One possible approach is to PCR amplify or chemically synthesize
genes of interest and to express them in a suitable host in order to study their function. For bacterial genes, Escherichia coli
is often used as the expression host but, depending on the origin and nature of the genes of interest and the test system
used to evaluate their putative function, other expression systems may be preferable. In this study, we developed a system
to evaluate the role of secreted and surface-exposed proteins from Gram-positive bacteria in the human gut microbiota in
immune modulation. We chose to use a Gram-positive host bacterium, Bacillus subtilis, and modified it to provide an
expression background that behaves neutral in a cell-based immune modulation assay, in vitro. We also adapted an E. coli –
B. subtilis shuttle expression vector for use with the Gateway high-throughput cloning system. Finally, we demonstrate the
functionality of this host-vector system through the cloning and expression of a flagellin-coding sequence, and show that
the expression-clone elicits an inflammatory response in a human intestinal epithelial cell line. The expression host can
easily be adapted to assure neutrality in other assay systems, allowing the use of the presented presentation system in
functional metagenomics of the gut and other ecosystems.
Citation: Dobrijevic D, Di Liberto G, Tanaka K, de Wouters T, Dervyn R, et al. (2013) High-Throughput System for the Presentation of Secreted and Surface-
Exposed Proteins from Gram-Positive Bacteria in Functional Metagenomics Studies. PLoS ONE 8(6): e65956. doi:10.1371/journal.pone.0065956
Editor: Stefan Bereswill, Charite´-University Medicine Berlin, Germany
Received February 12, 2013; Accepted April 30, 2013; Published June 14, 2013
Copyright:  2013 Dobrijevic et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The research leading to these results has received funding from the European Community’s Seventh Framework Programme (FP7/2007–2013) under
grant agreements nu215553-2 ("Crosstalk") and HEALTH-F4-2007-201052 ("MetaHIT"). The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: maarten.vandeguchte@jouy.inra.fr
Introduction
Metagenomics has transformed modern microbiology, allowing
us to study microorganisms that have been refractory to cultivation
in the laboratory. Through the use of metagenomic approaches
the amount of new information regarding complex ecosystems is
rapidly increasing, as exemplified by the recent publication of a
catalog of 3.3 million bacterial genes from the human gut
microbiota [1]. In parallel, there are strong indications that the gut
microbiota plays a pivotal role in human health, going far beyond
its accepted function in the digestion and energy harvesting of
alimentary components. Correlation studies of gut microbiota
composition and disease parameters strongly suggest a role of the
microbiota in (the prevention of) inflammatory bowel diseases,
obesity and other diseases [2–5], while experiments in mice
indicate a role in hitherto unsuspected processes like the
maturation and modulation of the immune system [6–8] and
even in behavior [9].
The next challenge is to move from correlations to functional
relationships, i.e. to the identification of the bacterial effectors
responsible for the observed effects, and the description of the
mechanisms involved. Important progress has been made in mice
experiments, where especially the establishment of germ-free and
genetically modified mice have been major breakthroughs,
allowing to test the effects of specific bacterial populations and
to get a hold on their mode of action. To predict effects in humans,
human cell cultures have been instrumental, notably in the field of
immune modulation. Cell-based assays not only permit to test the
effects of bacteria within the context of living human cells, but also
to study the underlying cellular mechanisms. Importantly, they
constitute a powerful and straightforward approach allowing the
parallelized functional screening of high numbers of bacterial
strains [10–12].
In the context of metagenomic studies, individual bacterial
strains are usually not available because they never have been, or
even could be, isolated and cultured in the laboratory. An
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approach to circumvent this problem consists of the generation of
metagenomic libraries with large DNA inserts in Escherichia coli
(e.g. [13,14]). Alternatively, in a directed approach genes of
potential interest may be identified by in silico analyses of
metagenomic data, amplified by PCR or chemically synthesized,
and expressed in host bacteria which can then be brought into
contact with human cell cultures. Usually E. coli, for which high-
throughput cloning systems like the Gateway system for site
specific recombination based cloning [15] have been developed, is
used as the heterologous expression host.
Genes of potential interest identified in metagenomic data may
encode surface proteins or secreted proteins from Gram-positive
bacteria, however, which constitute clear examples of proteins
where a Gram-positive expression host would be preferred over E.
coli with its Gram-negative cell envelope architecture [16]. In the
case of the study of immune modulation properties of the human
GI tract microbiota this is an important consideration, as Gram-
positive bacteria make up roughly 50% of the GI tract microbiota
[17], and a growing number of studies on probiotic bacteria
attribute immune-modulation activity to surface associated and
extracellular proteins [18].
Bacillus subtilis, a widely studied Gram-positive model bacterium,
constitutes a particularly attractive host due to its naturally high
secretory capacity [19]. B. subtilis is a genetically highly amenable
organism for which a large body of information and a variety of
genetic tools are available. The laboratory strain B. subtilis 168 can
develop natural competence [20], and therefore appears suitable
for establishing robust and straightforward high-throughput
transformation protocols.
These considerations lead us to develop a host-vector system for
high-throughput cloning and inducible expression of heterologous
genes in B. subtilis. An E. coli – B. subtilis shuttle vector which allows
conditional expression of a gene of interest was converted to a
Gateway-cloning compatible vector, and a B. subtilis host was
genetically modified to make it compatible with a cell-based in vitro
screen for immune modulation.
Materials and Methods
Bacterial Strains and Plasmids
The bacterial strains and plasmids used in this study are listed in
Table 1. E. coli and B. subtilis were grown at 37uC in Luria-Betani
(LB) broth with agitation or on the same medium solidified with
1.5% agar. Antibiotics were added where appropriate. For B.
subtilis, erythromycin was used at 30 mg/mL, tetracycline at
10 mg/mL, spectinomycin at 50 mg/mL and chloramphenicol,
kanamycin, and phleomycine at 5 mg/mL. For E. coli, spectino-
mycin was used at 100 mg/mL, ampicilin at 100 mg/mL and
kanamycin at 25 mg/mL.
Deletion of genes from the B. subtilis chromosome was achieved
through double crossing over recombination, replacing deleted
sequences with antibiotic resistance markers. For this purpose,
1.5 kb genome fragments upstream and downstream of the
interval to be deleted were amplified by PCR and joined to an
antibiotic cassette in a joining PCR reaction [21]. The resulting
PCR product was then used to transform B. subtilis competent cells
according to [22] with appropriate antibiotic resistance selection.
Chromosomal modifications were verified by PCR analysis.
pDG148-GW was constructed using E. coli DB3.1 as a host for
transformations. The Gateway reading frame cassette A (RfA,
Invitrogen) was cloned in the EcoRV site of pBluescript SK+
(Stratagene). The orientation was verified by restriction with EcoRI
and the plasmid with RfA orientated in the SacI-KpnI direction was
selected and called pSK-A. The Gateway cassette RfA was then
recovered from pSK-A after digestion with HindIII and XbaI, and
ligated to pDG148 digested with the same enzymes to yield
pDG148-GW (Fig. 1A).
Genes to be expressed in B. subtilis were amplified for cloning in
pDG148-GW as schematically represented in Fig. 1B. Full-length
coding sequences (CDS) were amplified by nested PCR using a set
of gene specific primers and a set of universal primers in a 1:4
ratio, and Phusion High Fidelity DNA polymerase (Finnzymes).
CDS-specific primers were designed using PrimerDesigner1.0 (N.
Pons, unpublished) so that the length of the CDS-specific primer
sequences was at least 18 b and if necessary longer to obtain a
theoretic annealing temperature of 55uC minimum (nearest-
neighbor method [23]), and start and stop codons were
systematically changed to ATG and TAG (amber), respectively.
The Amber stop codon was used to permit C-terminal tagging of
the protein in B. subtilis amber suppressor strains [24]. The
resulting PCR products contain the CDS preceded by an
AAAGGAGGC sequence to constitute a strong ribosome binding
site (RBS) in B. subtilis (http://partsregistry.org). Between this
sequence and the start codon, we included the TCTTCA
sequence, thus creating a SapI recognition sequence (GCTCTTC)
(Fig. 1B). This restriction site allows the direct utilization of the
pDONR-gene by restriction/ligation cloning methods. RBS and
CDS are flanked by the site specific recombination sites attB1.1
and attB2.1 [25]. The amplification products were cloned in
pDONR223 (Invitrogen) by site-specific recombination between
the attB1.1 and attB2.1 sites and the attP1 and attP2 sites,
respectively, present on the plasmid, in vitro, using BP clonase II
(Invitrogen) according to the recommendations of the supplier,
followed by transformation of OneShotR TOP10 chemically
competent E. coli (Invitrogen) with selection for spectinomycin (this
E. coli strain allowing the counter selection of pDONR223 without
insert). The resulting entry clones (25–50) were pooled and the
plasmid inserts, now flanked by attL1 and attL2, were transferred
to pDG148-GW by site-specific recombination between the attL1
and attL2 sites and the attR1 and attR2 sites, respectively, present
on the latter plasmid, in vitro, using LR clonase II (Invitrogen),
followed by transformation of E. coli TOP10 with selection for
ampicilin. After each transformation, transformant colonies were
pooled and plasmids extracted using a QIAprep Spin Miniprep
Kit (Qiagen). The presence of inserts in pDONR223 and
pDG148-GW was verified by digestion with BsrGI and EcoRI
(New England Biolabs), respectively, and PCR amplifications
using the pDONR223-specific primers 59-CCCAGTCAC-
GACGTTGTAAAACG and 59-GTAACATCAGAGATTTT-
GAGACAC. The plasmid pool obtained after LR recombination
and transformation was used to transform chemically competent
E. coli TG1, in order to generate multimeric plasmids suitable for
transformation of competent B. subtilis [26]. Resulting clones were
pooled, plasmids extracted and used to transform B. subtilis
according to [22]. Three B. subtilis clones were verified by colony
PCR using the vector-specific primers 59-CGCACCCTGAA-
GAAGATTTA and 59-GCCGACTCAAACATCAAATC. One
clone was kept for further study.
The gfp-mut2 gene, encoding a variant of green fluorescent
protein (GFP) with improved photo-stability and brightness [27],
was amplified from plasmid DNA (A. Chastanet, pers. comm.).
Genes coding for secreted and cell-wall bound forms of the E. coli
flagellin, obtained by cloning of the fliC coding sequence in pSEC
[28] or pCWA [29], respectively (A. Barinov, personal comm.),
were amplified from plasmid DNA. The nuclease encoding gene
SA0746 was amplified from Staphylococcus aureus N315 genomic
DNA.
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Table 1. Bacterial strains and plasmids used in this study.
Strains Genotype Relevant properties Reference
B. subtilis
168 trpC2 [45]
KA8AX 168 derivative; Depr Dwpr Dmpr DnprB D bpr DnprE Dvpr
DaprE aprX::spc
deficient in 9 proteases [42]
VI7686 168 derivative; (yvyD-yvzG-fliT-fliS-fliD-yvyC-hag)::phleo deficient in flagellin production this work
VI7692 KA8AX derivative; (yvyD-yvzG-fliT-fliS-fliD-yvyC-hag)::phleo deficient in 9 proteases and flagellin production this work




DB3.1 F- gyrA462 endA1 D(sr1-recA) mcrB mrr hsdS20(rB-, mB-) supE44
ara-14 galK2 lacY1 proA2 rpsL20(SmR) xyl-5 l– leu mtl1
mutation in the gyrase allows the propagation
of plasmids containing the ccdB gene
Invitrogen
One ShotHTOP10 F- mcrA D(mrr-hsdRMS-mcrBC) w80lacZDM15 DlacX74 recA1
araD139 D(ara-leu) 7697 galU galK rpsL (StrR)
endA1 nupG l-
host for cloning with counter selection of ccdB Invitrogen
TG1 F’ [traD36 proAB+ lacIq lacZDM15]supE thi-1 D(lac-proAB)
D(mcrB-hsdSM)5, (rK- mK-)
generation of plasmid multimers for use in
transformation of B.subtilis competent cells
Lucigen
Plasmids
pDONR223 Spcr ccdB+ Gateway entry vector Invitrogen
pDG148 Kanr Ampr Phlr E. coli – B. subtilis shuttle expression vector [31]
pBluescript SK+ Ampr Multiple cloning site plasmid with pUC origin Stratagene
pSK-A Ampr Cmr ccdB+ pBluescript SK+ with RfA Gateway cassette This work
pDG148-GW Kanr Ampr Cmr ccdB+ Gateway adapted pDG148 this work
pDGnuc Kanr Ampr pDG148-GW derivative containing the
staphylococcal nuclease gene (SA0746)
this work
pDGfliC-SEC Kanr Ampr pDG148-GW derivative containing the
E. coli fliC gene with signal peptide
this work
pDGfliC-CWA Kanr Ampr pDG148-GW derivative containing the
E. coli fliC gene with signal peptide and
cell wall anchor
this work




Figure 1. Schematic representation of the high-throughput cloning strategy. A. B. subtilis Gateway expression vector pDG148-GW with an
inducible Pspac promoter. lacI, lac repressor gene; AmpR, kanR, phlR, CmR, genes providing resistance to ampicilin, kanamycin, phleomycin, or
chloramphenicol, respectively; ccdB, gene coding for the cytotoxic CcdB protein. B. Full-length coding sequences (CDS) are amplified by nested PCR
using a set of CDS-specific (primary) primers and a set of universal (secondary) primers. The resulting PCR product contains the CDS preceded by a
synthetic SD sequence (brackets) and a SapI restriction site (underlined). attB1.1 and attB2.1 sites for site-specific recombination are indicated by
braces; start and stop codons of the CDS, in italic-bold.
doi:10.1371/journal.pone.0065956.g001
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Heterologous Gene Expression in B. subtilis and Protein
(activity) Detection
The expression of genes cloned in pDG148-GW in B. subtilis
was induced by the addition of 2 mM Isopropyl b-D-1-
thiogalactopyranoside (IPTG) to exponentially growing cultures
(OD600= 0.4), after which incubation was continued for 3 hours.
GFP expression was observed under the microscope. Nuclease
activity was measured in the culture supernatant using a
spectrophotometric assay as described in [30]. Flagellin in
bacterial cell wall fractions was detected by Western blotting:
bacteria from 2 mL of a culture in which flagellin production had
been induced were harvested by centrifugation, washed twice with
ice-cold phosphate-buffered saline (PBS), resuspended in 100 mL
of 10 mM Tris-HCl (pH 8) containing sucrose (1M), lysozyme
(Sigma, 5 mg/mL), and a protease inhibitor cocktail (Roche), and
incubated for 90 min at 37uC. The suspension was then
centrifuged at 10,000 rpm for 18 min at 4uC, and the supernatant,
corresponding to the cell-wall fraction, was subjected to SDS-
polyacrylamide gel electrophoresis (12.5% acrylamide). Proteins
were transferred to a nitrocellulose membrane, and probed with
rabbit polyclonal antibodies to E. coli flagellin (Abcam, 1:20,000
dilution). Interactions were identified using goat anti-rabbit IgG
antibodies coupled to peroxidase (Sigma, 1:10,000 dilution), and
ECL detection (GE Healthcare) according to the recommenda-
tions of the supplier.
Immune Modulation Assays
A human colon epithelial cell line HT-29 clone carrying a
chromosomally located luciferase reporter gene under the control
of an NF-kB dependent promoter (HT-29/NF-kB-luc-E, H.
Blottie`re, pers. comm.) was used to evaluate immune modulation
effects of B. subtilis strains and heterologously expressed flagellin.
Alternatively, HEK-BlueTM TLR5 (Invivogen), a human embry-
onic kidney cell line, HEK293, that stably co-expresses human
TLR5 and an NF-kB-inducible SEAP reporter gene, was used to
quantify the response to flagellin. HT-29/NF-kB-luc-E cells were
grown in RPMI 1640 (Lonza) and HEK- Blue TLR5 cells in
DMEM (Lonza). Both culture media were supplemented with
2 mM L-glutamine, 50 IU/mL penicillin, 50 mg/mL streptomy-
cin and 10% (or 20% for HEK-Blue TLR5) heat-inactivated fetal
calf serum (FCS, Lonza). Cells were grown in a humidified 5%
CO2 atmosphere (or 10% for HEK-Blue TLR5) at 37uC. The
HT-29 reporter cell line was seeded at 56104 cells per well in 96-
well plates (3917 assay plate, Costar, Cambridge, MA) and
incubated for 48h in 100 ml of complete RPMI. The RPMI
medium was refreshed before the immune modulation assay. For
TLR5 stimulation 156103 HEK-Blue TLR5 cells were seeded per
well. Induction of recombinant protein expression in B. subtilis was
performed as described above. An amount of bacterial culture
needed to prepare 100 mL of bacterial suspension with an
OD600nm of 0.5 was centrifuged, after which the bacterial pellet
was washed and resuspended in 100 mL of RPMI or DMEM.
10 mL (56106 bacterial cells) were then added to the HT-29/NF-
kB-luc-E (MOI= 25) or HEK-Blue TLR5 cells (MOI= 333) in a
final volume of 100 mL. Alternatively, 10 mL of filtered bacterial
culture supernatant (0.22 mm pore size filters (Millex GP,
Milipore)) was used. Tumor necrosis factor alpha (TNF-a)
(PeproTech, Rocky Hill, NJ)) and Salmonella typhimurium flagellin
(FLA-ST) (Invivogen) where used where appropriate at final
concentrations of 1 ng/mL and 10 ng/mL, respectively. For HT-
29 cells, after 6 hours 50 mL of the RPMI medium was removed
and luciferase reporter activity in the HT29 cells was measured
using the One-Glow Luciferase Assay System (Promega) according
to the manufacturer’s instructions and a Tecan Spectrafluor Plus
apparatus. Where appropriate, the removed medium was frozen at
280uC for further analysis, and 10 mL of this medium was used to
quantify the amount of secreted IL8 by enzymed-linked immuno
sorbent assay (ELISA; Biolegend, San Diego, CA) according to the
manufacturer’s recommendations. For HEK- Blue TLR5 cells,
after 24 hours of stimulation, SEAP reporter activity was measured
using the QUANTI-BlueTM SEAP detection reagent according to
the manufacturer’s recommendations. For each assay, three wells
were used and the mean result for the three wells considered as the
assay result. All assays were performed in triplicate.
Results
High-throughput Gene Cloning and Expression in Bacillus
subtilis
The development of a high-throughput system for the
presentation of proteins from Gram-positive bacteria involved
three criteria to meet the specific needs of functional metage-
nomics studies: the choice of a suitable host bacterium, a cloning
strategy, and a cloning vector.
We chose to use a Gram-positive bacterium as a host, a
prerequisite for the correct presentation of surface exposed and
secreted proteins derived from Gram-positive bacteria, selected in
metagenomic datasets. B. subtilis was chosen as the most
exhaustively studied Gram-positive model bacterium, amenable
to genetic modification to adapt it to the specific needs of a
particular functional genomics project (see below).
For gene cloning we adopted the Gateway system [15] for site-
specific recombination based cloning. We adapted the E. coli – B.
subtilis shuttle vector pDG148 for use with this high-throughput
cloning system by the introduction of the Gateway cassette. The
resulting destination vector, pDG148-GW (Fig. 1A), allows the
cloning of genes under the control of the IPTG-inducible Pspac
promoter [31] for expression in B. subtilis. The subsequent steps of
gene amplification, cloning and expression were established using
the gfp-mut2 gene as an example. The GFP coding sequence was
amplified using a nested PCR approach (Fig. 1B), adding an
attB1.1 site and a synthetic ribosome binding site to the 59 end and
an attB2.1 site to the 39 end. The amplification product was cloned
in pDONR223 (Invitrogen) by site-specific recombination between
the attB1.1 and attB2.1 sites and the attP1 and attP2 sites,
respectively, present on the plasmid. The plasmid insert from the
resulting entry clone, now flanked by attL1 and attL2, was
transferred to pDG148-GW by site-specific recombination be-
tween the attL1 and attL2 sites and the attR1 and attR2 sites,
respectively, present on the latter plasmid, and the resulting
plasmid was used to transform E. coli TG1 in order to generate
multimeric plasmids, that were subsequently used to transform
naturally competent B. subtilis (as transformation of competent B.
subtilis with multimeric plasmids is 1000 fold more efficient than
transformation with monomeric plasmids [26]). In B. subtilis 168,
GFP expression could readily be induced by the addition of IPTG
while no fluorescence was observed in the absence of IPTG (results
not shown). Together, these results validate the functionality of the
gene amplification, cloning and expression strategy.
B. subtilis Host Adaptation for Functional Metagenomics
Studies
Protein presentation systems permit to explore the activities of
individual heterologous proteins. In our case, we were interested in
the use of a presentation system for the evaluation of potential
immune modulation effects of heterologous proteins, in an assay
where expression clones or their culture supernatants are brought
into contact with human cell cultures. The assay we used monitors
Protein Presentation for Functional Metagenomics
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the activation of NF-kB, a key factor in the establishment of
inflammatory responses [32], in an intestinal epithelial cell line
[12]. B. subtilis 168 itself appeared to induce NF-kB activation in
this assay (Fig. 2A), and we hypothesized that this effect could be
ascribed to its flagellin. Flagellins of other bacteria have been
described as potent NF-kB activators, acting through the
activation of the TLR5– MyD88 signaling cascade [33,34]. We
therefore eliminated the flagellin and surrounding genes from the
B. subtilis genome, and the resulting strain, VI7686, appeared to
have lost its capacity to induce NF-kB activation (Fig. 2A). This
result showed that an adapted B. subtilis strain could fulfill the
requirement of background neutrality in the assay used.
A property of B. subtilis that is known to interfere with the
efficient production of heterologous (extracellular) proteins is the
production of a multitude of proteases. We therefore decided to
use a 168-derived strain in which eight genes coding for
extracellular proteases and one gene for an intracellular protease
have been inactivated (strain KA8AX, [35]), and to eliminate the
flagellin and surrounding genes from that background. The
resulting strain, VI7692, was verified to behave neutral in the
NF-kB activation assay (Fig. 2A), and its utility will be discussed
below (performance of the host-vector system).
Two further deletions were made in strain VI7692 that could
potentially improve the secretion and surface exposition of
heterologous proteins: deletion of the eps operon and of the tasA
gene that together have been reported to be involved in the
production of an extracellular matrix [35]. The resulting strain, B.
subtilis VI7695, still behaved neutral in the NF-kB activation assay
(Fig. 2A), but showed an pronounced filamenting phenotype
(Fig. 2B) where cells did not separate until stationary phase, and a
viscous cell pellet after centrifugation. A similar phenotype was
observed for a strain in which only the eps operon was deleted
(results not shown). The different host adaptations did not
significantly affect bacterial growth (results not shown).
In addition to their evaluation in the NF-kB activation assay,
the B. subtilis strains described above were tested for their effect on
the secretion of the chemokine IL8. IL8 plays an important role in
the recruitment and activation of neutrophils at sites of infection or
injury, and its expression is under the control of not only NF-kB,
but also of several other signaling pathways [36]. The measure-
ment of the expression of this chemotactic and inflammatory
cytokine thus provides a complementary view on the capacity of B.
subtilis to interact with gut epithelial cells. The results presented in
Fig. 2C show that where B. subtilis 168 strongly induces IL8
secretion, the flagellin deletion mutants have lost most of this IL8
modulation capacity. When brought into contact with the latter
bacteria, HT-29 cells secrete only about 15% of the quantity of
IL8 they secrete when in contact with B. subtilis 168. The strains
we present here may thus also be used in immune-modulation
assays with an IL8 readout. The remaining low-level IL8 secretion
Figure 2. Properties of B. subtilis wt and mutant strains. A. Effect
of B. subtilis strains on NF-kB activation. Bars indicate the relative
activity of a luciferase reporter gene under the control of an NF-kB
dependent promoter in an intestinal epithelial cell line (HT-29), in vitro.
Bacterial strains are indicated on the abscissa. b, live bacteria from
exponentially growing cultures; s, culture supernatant; -, HT-29 cells
only; T1, TNF-a (1 ng/ml). Mean values of three independent
experiments are presented. Error bars indicate the SEM. F-BS, presence
(+) or absence (2) of B. subtilis flagellin gene; P, presence or absence of
multiple B. subtilis protease genes; EM, presence or absence of
extracellular matrix genes (eps and tasA). B. B. subtilis phenotypes as
viewed by phase-contrast microscopy. Exponentially growing bacteria
are shown, 100X magnification. C. Effect of B. subtilis strains on IL8
secretion. Bars indicate the concentration of secreted IL8 after
incubation of HT-29 cells with the bacteria or bacterial culture
supernatants indicated on the abscissa. Abbreviations as in Fig. 2A.
The same bacterial cultures were used for the NF-kB activation assay
shown in Fig. 2A and the IL8 secretion assay shown in Fig. 2C.
doi:10.1371/journal.pone.0065956.g002
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may be due to the activation of other signaling pathways than the
NFkB pathway by bacterial surface molecules, or by cellular stress
[36].
Performance of the Host – Vector System
The effect of host adaptations on the production of heterologous
secreted proteins was evaluated in two ways. First, using the
strategy described above we cloned and expressed the Staphylococcus
aureus nuclease (Nuc) encoding gene, and measured the nuclease
activity in culture supernatants. The results presented in Fig. 3
show that in strain VI7686 (lacking flagellin), the nuclease activity
reached a maximum about three hours after induction and
subsequently declined to completely disappear after 5 h 30 of
induction. Roughly the same activity curve was observed in the wt
strain 168 (results not shown). In strain VI7692 (deficient in both
flagellin and 9 proteases) nuclease activity reached, after about 3
hours, a 1.5 fold higher maximum than in the first two strains, and
no decline was observed afterwards. The additional deletion of the
eps and tasA genes in strain VI7695 did not improve nuclease
production, but on the contrary retarded production while the
maximum activity was comparable to the lower level observed in
the wt strain 168. On the basis of this result and the earlier
mentioned filamenting phenotype the VI7695 background was
discarded for further experiments.
We then expressed a secreted form of the E. coli flagellin, by
cloning the fliC gene from E. coli DH10b fused in frame to the
usp45 signal sequence from the Gram-positive bacterium Lacto-
coccus lactis (A. Barinov, unpublished) in pDG148-GW. The
resulting plasmid, pDGfliC-SEC, was used to transform B. subtilis
VI7686 and VI7692 and, after induction of flagellin production,
bacteria and culture supernatants were used to study NF-kB
induction in human gut epithelial HT-29 cells, in vitro. While none
of the washed bacterial cells induced NF-kB activation (results not
shown), the supernatants of strain VI7692 (pDGfliC-SEC) in
which flagellin production had been induced during 3 hours
clearly induced NF-kB activation (Fig. 4). No activation of NF-kB
was observed when flagellin production had not been induced.
Surprisingly, when using the supernatant of induced cultures of
strain VI7686 (pDGfliC-SEC), no activation at all was observed
suggesting the complete degradation of the heterologous flagellin
by the proteases produced by this strain. In order to verify that this
result was characteristic for this host strain and not due to plasmid
rearrangements, we isolated pDGfliC-SEC from this strain and
used it to transform strain VI7692, and vice versa. Testing the
resulting strains corroborated that the NF-kB activation results
depended on the host background (results not shown). The
different behavior of nuclease and flagellin in the VI7686
background may be explained by a differential sensitivity of
nuclease and flagellin towards the various B. subtilis proteases.
The results of both nuclease and flagellin expression and the
accompanying activity assays confirmed the functionality of the
host – vector system presented in this work. Both also showed that
Figure 3. Activity of S. aureus nuclease in different B. subtilis backgrounds. Growth (OD600 nm) and nuclease relative activity in culture
supernatants (scale 1–10) are presented for three different B. subtilis backgrounds. Filled diamonds, growth; open squares, nuclease relative activity.
Time is time after the beginning of nuclease induction by addition of 2 mM IPTG. Mean values of three independent experiments are presented. Error
bars indicate the SEM.
doi:10.1371/journal.pone.0065956.g003
Figure 4. Immune modulation effect of secreted E. coli flagellin
in different B. subtilis backgrounds. Bars indicate the relative
activity of a luciferase reporter gene under the control of an NF-kB
dependent promoter in an intestinal epithelial cell line (HT-29), in vitro.
Bacterial backgrounds of which the culture supernatant was tested are
indicated on the abscissa: grey bars, supernatants of bacterial cultures
in which flagellin (if present) had been induced with IPTG; open bars,
supernatants of bacterial cultures in which flagellin had not been
induced. -, HT-29 cells only; T1, TNF-a (1 ng/ml). Mean values of three
independent experiments are presented. Error bars indicate the SEM. F-
BS, presence (+) or absence (2) of B. subtilis flagellin gene; P, presence
or absence of multiple B. subtilis protease genes; pDG, presence or
absence of pDG148 (empty vector); pF-EC, presence or absence of
pDGfliC-SEC encoding a secreted form of E. coli flagellin.
doi:10.1371/journal.pone.0065956.g004
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the protease deficient background largely improved the production
of heterologous secreted proteins, while the additional deletion of
the eps and tasA operons did not result in further improvement or
even seemed less optimal and caused a filamenting phenotype.
The results of the flagellin expression assays in VI7692 demon-
strate the utility of the system for protein presentation in screening
for immune modulation properties.
Presentation of Bacterial Surface Proteins
Bacterial surface proteins play an important role in bacteria-
host interactions. Among the different classes of Gram-positive
bacterial surface proteins (summarized in [37,38]), a specific class,
known as LP6TG proteins by the sequence motif they share, relies
on a sortase for its covalent attachment to the bacterial cell wall
[39]. B. subtilis contains two putative sortases [40] and the
functionality of one of them has recently been demonstrated [41].
We chose to take the example of an LP6TG protein to validate
the use of our system for the presentation of heterologous surface
proteins and the subsequent evaluation of their immune modu-
lation potential. For this purpose, we expressed an E. coli flagellin
which, in addition to the N-terminal USP45 signal peptide,
contained a C-terminal cell-wall anchoring LP6TG motif derived
from the Streptococcus pyogenes M6 protein. The results of Western
blotting using antibodies directed against the E. coli flagellin
showed the presence of the flagellin in the bacterial cell wall
fraction of the strain expressing the cell wall bound flagellin, while
no flagellin was detected in the cell pellet of the strain expressing
the secreted flagellin (Fig. 5A). We then studied the NF-kB
activation potential of the bacterial cell pellet, using a human
embryonic kidney HEK293 reporter cell line expressing the
flagellin–specific Toll-like receptor TLR5 (HEK-BlueTM TLR5,
Invivogen). While no NF-kB activation was observed with the
resuspended bacteria from the control strain containing pDG148
or the strain expressing the secreted form of flagellin, the bacteria
expressing the cell wall bound form of the flagellin clearly induced
NF-kB activation (Fig. 5B). No NF-kB activation was observed in
a HEK-BlueTM NF-kB reporter cell line without TLR5 (results not
shown). Together, these results show that the heterologous
LP6TG containing flagellin is expressed and at least partly
retained at the bacterial cell surface, and responsible for NF-kB
activation. They thus confirm the utility of our presentation system
for the evaluation of the immune modulation potential of bacterial
surface proteins.
Discussion
The increasing amounts of sequence data and associated results
of correlation studies generated in metagenomics projects allow
the formulation of hypotheses concerning bacterial gene functions
in relation to the ecosystem studied. The experimental validation
of these hypotheses asks for new functional genomics approaches
as the majority of bacterial species from the ecosystem-specific
microbiota have never been cultured in the laboratory, and
sequence data are mostly generated using Next Generation
Sequencing technologies (NGS) that circumvent the need of
cloning DNA fragments. As a result, specific bacterial species or
clone libraries with identified insert content are most often not
available for direct testing.
An alternative directed approach comes in sight as the increased
predictive power from large datasets (enhanced in silico analysis
capacities and accumulating a priori knowledge) will more and
more allow to focus on relatively small, but still considerable, sets
of genes (in the hundreds to thousands range) of potential interest,
of which the separate cloning and screening can be envisaged
using high-throughput methods. In this context, we realized that
surface exposed and secreted proteins from Gram-positive bacteria
constitute a category of proteins that may be hard to evaluate by
cloning in E. coli due to the different architectures of the cell
envelopes of Gram-positive and Gram-negative bacteria, and that
a Gram-positive host would thus be preferable for these proteins.
In addition, the screening for biological activity of these proteins
requires that the expression host behaves neutral in the assay
system used. We therefore set out to develop a compatible high-
throughput protein presentation system that would, in our case,
permit the evaluation of the immune modulation potential of
individual proteins from these categories.
This objective implied the development of an integrated system
comprising i) a suitable expression vector, compatible with high-
throughput cloning strategies and allowing target gene expression
in a Gram-positive host, and ii) a suitable host that would behave
Figure 5. Presence and immune modulation effect of E. coli
flagellin in B. subtilis cell wall fractions. A. Western blot detection
of E. coli flagellin in cell wall fractions of B. subtilis expressing the cell
wall attached (lane 1) or the secreted (lane 2) form of flagellin, and a
control expressing no flagellin (lane 3); Arrow points to the cell wall
attached flagellin at the expected position of approximately 63 kDa. B.
NF-kB activation capacity of washed B. subtilis VI7692 bacteria
expressing a secreted (sec) or cell wall attached (cwa) form of E. coli
flagellin. Grey bars, bacteria in which flagellin (if present) had been
induced with IPTG; open bars, bacteria in which flagellin had not been
induced. Bars indicate the relative activity of an SEAP reporter gene
under the control of an NF-kB dependent promoter in HEK-Blue TLR5
cells, in vitro. -, HEK-Blue TLR cells only; *, S. typhimurium flagellin
(10 ng/mL); pDG, presence (+) or absence (2) of pDG148 (empty
vector); pF-EC(sec), presence or absence of pDGfliC-SEC encoding a
secreted form of E. coli flagellin; pF-EC(cwa), presence or absence of
pDGfliC-CWA encoding a cell wall attached form of E. coli flagellin. One
representative experiment is shown out of two repetitions each
performed in triplicate.
doi:10.1371/journal.pone.0065956.g005
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neutral in the envisaged immune modulation assay. For this
purpose, we adapted the widely used E. coli – B. subtilis shuttle
expression vector pDG148 for use with the Gateway high-
throughput cloning system, and chose to use B. subtilis as the
expression host. We also adapted a B. subtilis strain that had earlier
been optimized for protein production through the deletion of
multiple protease coding genes [42] to make it behave neutral in
the immune modulation assay. It appeared that one chromosomal
deletion encompassing the flagellin coding gene and six surround-
ing genes sufficed to eliminate the pro-inflammatory, NF-kB
activating, behavior of the B. subtilis strain.
The expression and secretion of a heterologous flagellin capable
of eliciting an immune modulation response in human HT-29 gut
epithelial cells delivered the proof of principle of the utilization of
the newly developed host-vector system for the presentation of
secreted proteins. Moreover, we showed that the same flagellin
when equipped with a C-terminal LP6TG motif was at least in
part retained on the bacterial cell, and that the recombinant
bacterial cells acquired the capacity to elicit a pro-inflammatory
immune modulation response, thus demonstrating the utilization
of our system for the functional presentation of bacterial cell
surface proteins. This result contradicts earlier work with B. subtilis
where the authors concluded that the B. subtilis sortase, which
attaches the protein to the cell wall, does not recognize the
canonical LP6TG motif but only the LPDTS motif [41,43].
LP6TG proteins constitute only one type of surface proteins
specific to Gram-positive bacteria. Another important but often
overlooked class of proteins that can be surface exposed is
constituted by proteins that contain one or more trans-membrane
helices (TMHs) [37]. Due to the very different nature of the Gram-
positive and Gram-negative cell-envelopes, surface exposition of
this type of proteins from Gram-positive bacteria is expected to be
correctly reconstituted only in a Gram-positive expression host.
In the course of our work, the construction of two other
Gateway compatible expression vectors for use in a Gram-positive
host was reported [44] confirming the need for Gram-positive
vectors in this cloning system. These vectors are intended for the
use in L. lactis, however, a host less suited for our purpose as its
notorious acid production has a deleterious effect on the
eukaryotic cells used in the immune modulation assay.
The results presented here represent the enabling prerequisites
for a directed approach to the functional exploration of the Gram-
positive fraction of the gut microbiota, notably regarding immune
modulation. The host-vector system can easily be adapted to the
study of other functions or other ecosystems through the
adaptation of the expression host, to assure its neutrality in the
activity screen that will be employed.
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